Supplemental data

The following information is presented as supplemental data as required by the indentures governing the Company’s senior notes.

Condensed Consolidating Statements of Income



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
For the nine months ended September 30, 2018	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Patient service operating revenues	$	7,980,178		$	—		$	—	$	7,980,178
Provision for uncollectible accounts	(35,838		)	—			—		(35,838		)
Net patient service operating revenues	7,944,340			—			—		7,944,340
Other revenues	639,387			—			—		639,387
Total net operating revenues	8,583,727			—			—		8,583,727
Operating expenses	7,445,811			—			—		7,445,811
Operating income	1,137,916			—			—		1,137,916
Debt expense, including refinancing charges	(359,135		)	—			—		(359,135		)
Other income	10,583			—			—		10,583
Income tax expense	206,652			—			—		206,652
Net income from continuing operations	582,712			—			—		582,712
Net (loss) income from discontinued operations, net of tax	(147,829		)	20,773			298		(168,900		)
Net income	434,883			20,773			298		413,812
Less: Net income attributable to noncontrolling interests	(125,717		)	(6,961		)	—		(118,756		)
Net income attributable to DaVita Inc.	$	309,166		$	13,812		$	298	$	295,056


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Comprehensive Income



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
For the nine months ended September 30, 2018	Consolidated Total			Physician Groups			Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Net income	$	434,883		$	20,773		$	298	$	413,812
Other comprehensive loss	(33,976		)	—			—		(33,976		)
Total comprehensive income	400,907			20,773			298		379,836
Less: Comprehensive income attributable to the noncontrolling interests	(125,717		)	(6,961		)	—		(118,756		)
Comprehensive income attributable to DaVita Inc.	$	275,190		$	13,812		$	298	$	261,080


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Balance Sheets



	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
As of September 30, 2018	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
Cash and cash equivalents	$	448,215	$	—	$	—	$	448,215
Restricted cash and equivalents	91,940		—		—		91,940
Accounts receivable, net	1,847,086		—		—		1,847,086
Other current assets	594,474		—		—		594,474
Current assets held for sale, net	5,947,786		567,216		3,031		5,377,539
Total current assets	8,929,501		567,216		3,031		8,359,254
Property and equipment, net	3,275,636		—		—		3,275,636
Amortizable intangibles, net	97,609		—		—		97,609
Other long-term assets	352,384		—		—		352,384
Goodwill	6,702,659		—		—		6,702,659
Total assets	$	19,357,789	$	567,216	$	3,031	$	18,787,542
Current liabilities	$	3,435,483	$	—	$	—	$	3,435,483
Current liabilities held for sale	1,419,621		350,640		—		1,068,981
Payables to parent	—		78,496		3,031		(81,527		)
Long-term debt and other long-term liabilities	9,409,011		—		—		9,409,011
Noncontrolling interests subject to put provisions	1,064,412		—		—		1,064,412
Total DaVita Inc. shareholders’ equity	3,824,649		138,080		—		3,686,569
Noncontrolling interests not subject to put provisions	204,613		—		—		204,613
Shareholders’ equity	4,029,262		138,080		—		3,891,182
Total liabilities and shareholder’s equity	$	19,357,789	$	567,216	$	3,031	$	18,787,542


(1)	After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Cash Flows



	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For the nine months ended September 30, 2018	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
Cash flows from operating activities:
Net income	$	434,883		$	20,773		$	298		$	413,812
Changes in operating and intercompany assets and liabilities and non-cash items included in net income	947,365			77,229			(298		)	870,434
Net cash provided by operating activities	1,382,248			98,002			—			1,284,246
Cash flows from investing activities:
Additions of property and equipment	(705,659		)	(2,575		)	—			(703,084		)
Acquisitions	(113,526		)	—			—			(113,526		)
Proceeds from asset and business sales	135,268			—			—			135,268
Investments and other items	22,598			(1		)	—			22,599
Net cash used in investing activities	(661,319		)	(2,576		)	—			(658,743		)
Cash flows from financing activities:
Long-term debt	845,836			—			—			845,836
Intercompany	—			77,286			—			(77,286		)
Other items	(1,269,175		)	—			—			(1,269,175		)
Net cash (used in) provided by financing activities	(423,339		)	77,286			—			(500,625		)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(5,790		)	—			—			(5,790		)
Net increase in cash, cash equivalents and restricted cash	291,800			172,712			—			119,088
Less: Net increase in cash, cash equivalents and restricted cash from discontinued operations	270,565			172,712			—			97,853
Net increase in cash, cash equivalents and restricted cash from continuing operations	21,235			—			—			21,235
Cash, cash equivalents and restricted cash of continuing operations at beginning of the year	518,920			—			—			518,920
Cash, cash equivalents and restricted cash of continuing operations at end of the period	$	540,155		$	—		$	—		$	540,155


(1)	After elimination of the unrestricted subsidiaries and the physician groups.